Many interventions shown to be effective in clinical trials are never adopted in clinical settings. This study seeks to explore and address the reasons for non-adoption of an evidence-based psychosocial intervention (EBPI) that addresses anxiety, depression, and gastrointestinal (GI) symptoms among individuals with a common GI problem, irritable bowel syndrome (IBS). Approximately 30-50% of individuals with IBS report anxiety and depression, which is greater than the general population. IBS patients with anxiety and depression also report more severe IBS symptoms and lower quality of life than those without. However, an effective EBPI developed by our group has not been implemented outside of the experimental setting.

Using the Discover, Design, and Build framework, the purpose of this proposal is to 1) discover the barriers to clinical implementation from the perspective of both providers and patients and 2) iteratively develop a prototype to improve usability using a design-focused solution. Beginning with the original EBPI, which was designed and tested for in-person or telephone interactions, we will use focus groups with providers and patients to guide the re-design process and inform modifications to improve acceptability and usability.

The current EBPI has the potential to address adaptation of tested mental health treatments in other comorbid chronic conditions and improve the mental health of patients with chronic medical conditions. The intervention aims to provide structure, accountability, and support while addressing the gut-brain interaction comprehensively.